Follow us twitter facebook
Edition: Global
Click here to subscribe toour free weekly newsletter click here
Laws and regulations

US cosmetics industry calls for greater FDA role

The Personal Care Products Council is proposing to establish an additional layer of federal regulation over cosmetic products, and to increase the FDA role in the oversight of ingredients. With this groundbreaking initiative, the Council intends to end recurrent polemics on the safety of cosmetic products in the US.

Call for a new federal legislation

Lezlee Westine, PCPC’s President and CEO

Lezlee Westine, PCPC’s President and CEO

The Personal Care Products Council (PCP), the leading trade group representing the US cosmetics industry [1], has called for a new federal legislation that would strengthen and modernize regulatory oversight of the industry and create a greater role for the U.S. Food and Drug Administration (FDA) in assessing ingredient safety for personal care products.

The Council detailed its proposal in a letter to key health policy leaders in the Senate and House of Representatives. “The proposal represents the culmination of more than three years of planning and research,” said the Council in a release.

For decades, the industry has had an impeccable safety record under the existing requirements implemented by FDA under the Federal Food, Drug, and Cosmetic Act. Our products remain among the safest in the marketplace,” explained Lezlee Westine, the Council’s president and chief executive officer. “Nonetheless, we believe it is time to develop a more contemporary approach that includes a greater federal regulatory role.

Recurrent polemics

Westine emphasized the proactive nature of the PCPC’s announcement, which is being made in the absence of any specific public health risk or legislative mandate involving personal care products, which remain safe to use. “Rather, the industry is responding to American consumers who are requesting and deserving more transparency from government and industry while ensuring their ability to keep pace with continued demand for innovative products.

Indeed, the initiative is following recurrent polemics regarding the safety of cosmetics and their ingredients in the US. The introduction in Europe of regulatory provisions prohibiting carcinogenic, mutagenic and reprotoxic (CMR) substances in cosmetic products has also given arguments to several public action groups requiring a similar level of protection for US consumers. This even led to the adoption of a specific legislation in California [2] and several other legislative proposals in numerous other States.

Five-point plan

The Council is seeking to create formal processes for FDA to review ingredients for safety at the request of the public and stakeholder groups and to review all safety determinations made by the Cosmetic Ingredient Review (CIR) Expert Panel. No such FDA processes currently exist.

Toward that end, the PCPC has worked on a five-point plan that includes:

(1) Enhanced FDA Registration. Personal care products manufacturers who market their products in the United States would be required to:

  • Register with FDA all facilities where those products are manufactured.
  • File with FDA product ingredient reports disclosing all of the ingredients used in those products; and
  • Report to FDA any serious unexpected adverse event with a personal care product experienced by consumers.

(2) Safety levels for trace constituents. When requested or on its own initiative, FDA would be required to establish safe levels for trace constituents in cosmetic ingredients and finished products.

(3) New FDA Ingredient Review Process. Once a request has been made, or FDA unilaterally determines action is warranted, the agency would be required to review the safety of any ingredient intended for use in a personal care product and set safety use levels for such ingredient on a specified timetable. This initiative could dramatically increase the list of ingredients either prohibited or limited for use in cosmetics.

(4) New FDA oversight of CIR findings. The Council’s initiative would maintain the Cosmetic Ingredient Review (CIR) Expert Panel [3], which currently assesses the safety of cosmetic ingredients, but FDA would be required to review current and future CIR findings and determine if they are correct. If there are instances in which it determines a CIR finding is not correct, FDA would determine by guidance or regulations if, or under what conditions, the ingredient can be used safely in personal care products.

(5) FDA-Issued Good Manufacturing Practices. There are currently no compulsory Good Manufacturing Practices (GMP) applicable to cosmetic products in the US, despite that numerous cosmetics manufacturers voluntary comply with the guidelines published by the Personal Care Products Council or other bodies. Under the Council’s plan, the FDA would establish industry-wide GMP requirements.

The Council and its member companies have been proactively working with legislators to materialise their plan in a bill: HR 759, the Food and Drug Administration Globalization Act of 2009, introduced by Congressman John Dingell (D-MI).

Our companies commend Rep. Dingell for his ongoing work to better protect consumers and increase transparency. We look forward to working with the current and next Congress to ensure these changes are meaningful and attain the full force of federal law,” said Westine.

Vincent Gallon

Footnotes

[1] The PCP was founded in 1894, its more than 600 member companies manufacture, distribute, and supply the vast majority of finished personal care products marketed in the U.S. ICMAD (Independent Cosmetic Manufacturers and Distributors), the other trade organisation representing the US cosmetics industry, mainly gathers small and mid size enterprises.

[2] California Safe Cosmetics Act of 2005 (SB 484)

[3] The Cosmetic Ingredient Review was established in 1976 by the industry trade association (then the Cosmetic, Toiletry, and Fragrance Association, now the Personal Care Products Council), with the support of the U.S. Food and Drug Administration and the Consumer Federation of America. The seven CIR Expert Panel voting members are physicians and scientists who have been publicly nominated by consumer, scientific, and medical groups; government agencies; and industry. Expert Panel members must meet the same conflict of interest requirements as individuals serving on FDA advisory committees.

© 2010 - Premium Beauty News - www.premiumbeautynews.com
latest news
Focus
spip-vignette

A new trade show dedicated to clean beauty in London

Dubbed Clean Beauty in London the new trade show intends to gather experts, scientists, suppliers, brands, influencers and journalists under one roof “to build the future of clean beauty.” Taking place on October 12 & 13, 2020 at The Brewery, located at 52 Chiswell Street at the heart of London, the event aims to encourage (...)

read more
job opportunities
Experts’ views
India emerges as the next beauty giant

Asia Cosme Lab
India emerges as the next beauty giant

Thanks to a growing young population (first youth population in the world) and the emergence of a vast middle class, as well as a higher Internet connection from both urban and rural areas, India is set to emerge as the next beauty giant after China. Asia Cosme Lab took a deep dive in the fascinating Indian market, where both (...)

read more
Webinars
E-shop - latest publications
MARKET REPORT : Black & Multi-Hued Beauty Trends
4000.00 € excl. tax
Regulations on the registration of cosmetic products in China (part2)
95.00 € excl. tax
Safety of perfumes and cosmetics. Belarus, Kazakhstan and Russia
200.00 € excl. tax
Go to top ↑

Features

We use cookies to give you a better browsing experience. By continuing your visit to this site, you accept the use of cookies. Read more and set cookies
close